Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Other Non-Current Assets: 2010-2024

Historic Other Non-Current Assets for Altimmune (ALT) over the last 15 years, with Dec 2024 value amounting to $1.6 million.

  • Altimmune's Other Non-Current Assets fell 9.89% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 9.89%. This contributed to the annual value of $1.6 million for FY2024, which is 351.52% up from last year.
  • According to the latest figures from FY2024, Altimmune's Other Non-Current Assets is $1.6 million, which was up 351.52% from $363,000 recorded in FY2023.
  • Altimmune's 5-year Other Non-Current Assets high stood at $1.6 million for FY2024, and its period low was $363,000 during FY2023.
  • In the last 3 years, Altimmune's Other Non-Current Assets had a median value of $615,000 in 2022 and averaged $872,333.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first spiked by 660.22% in 2020, then tumbled by 40.98% in 2023.
  • Yearly analysis of 5 years shows Altimmune's Other Non-Current Assets stood at $977,238 in 2020, then declined by 10.77% to $872,000 in 2021, then fell by 29.47% to $615,000 in 2022, then crashed by 40.98% to $363,000 in 2023, then surged by 351.52% to $1.6 million in 2024.